Medicine
fromenglish.elpais.com
3 days agoThe pastry chef who patented an anti-cancer molecule that's been bought for over $8 billion
Petosemtamab, co-invented by Eduard Batlle, achieved high response rates and complete remissions in head and neck cancer trials and was sold to Genmab.